|
by HAF May 27, 2021 from HumansAreFree Website
She cites a study recently published from researchers at Washington University School of Medicine in St. Louis showing that the protection gained from mild COVID-19 illness,
The study found that of 19 people who had a mild COVID infection, 15 of them contained-antibody-producing cells,
The cells are present in the bone marrow and constantly secreting antibodies. According to the researchers:
People who were infected and never had symptoms also may be left with long-lasting immunity, the researchers speculated.
What needs to happen next are multiple studies looking into the response and antibody level of those who were completely asymptomatic and those with severe infection, which suggests a higher viral load.
The studies that have emerged regarding the protection one receives from a COVID infection all point to the idea that immunity may last a lifetime.
This would be on par with what we've seen with other coronaviruses. Natural infection provides robust protection in the form of T cells, B cells and antibodies.
For example, did you know people who have had SARS still have robust immunity 17 years later?
A study published in Nature explains,
Please keep in mind that testing "positive" for COVID doesn't mean you are infectious, and that's also true if you've already had COVID.
You can read more about that here.
Corroborating Information
An analysis of millions of coronavirus test results in Denmark found that people who had prior infection, were still protected 6 months after the initial infection.
Another study also found that individuals who recovered from the coronavirus developed "robust" levels of B cells and T cells (necessary for fighting off the virus) and,
Dr. Daniela Weiskopf, Dr. Alessandro Sette, and Dr. Shane Crotty from the La Jolla Institute for Immunology analyzed immune cells and antibodies from almost 200 people who had been exposed to SARS-CoV-2 and recovered.
The researchers found durable immune responses in the majority of people studied.
Antibodies against the spike protein of SARS-CoV-2, which the virus uses to get inside cells, were found in 98% of participants one month after symptom onset.
As seen in previous studies, the number of antibodies ranged widely between individuals. But, promisingly, their levels remained fairly stable over time, declining only modestly at 6 to 8 months after infection.
Virus-specific B cells increased over time. People had more memory B cells six months after symptom onset than at one month afterwards.
Although the number of these cells appeared to reach a plateau after a few months, levels didn't decline over the period studied.
Levels of T cells for the virus also remained high after infection. Six months after symptom onset, 92% of participants had CD4+ T cells that recognized the virus.
These cells help coordinate the immune response. About half the participants had CD8+ T cells, which kill cells that are infected by the virus.
A recent study published in Clinical Microbiology and Infection explains:
Final Thoughts & Important Considerations
It was great to see Dr. Ali Ellebedy bring up the point about reports earlier on and mainstream media claim that natural infection does not provide protection, and how this was a misinterpretation of the data.
This was done to stress the importance of vaccination. Anybody who was suggesting that natural infection was sufficient enough for long lasting protection at the time was, and still is subjected to extreme amounts of criticism and even censorship.
I recently published an article regarding Harvard epidemiologist and vaccine expert Dr. Martin Kulldorff.
He is one of many who has been subjected to censorship for claiming that previously infected people do not need to take the vaccine, and that everybody does not need to take the vaccine.
I also recently published an article about viral immunologist, Professor at the University of Guelph, and vaccine expert Dr. Bryan Bridle, who explained several concerns regarding the rollout of COVID vaccines and expressed how people are not being tested for antibodies before getting vaccinated.
This way the vaccines could perhaps go to those who actually need it.
The push for mass vaccination doesn't really add up and conform to the science. Telling people that nothing is going to go back to normal until everybody is vaccinated again, from a scientific standpoint, just doesn't make any sense.
Dr. Sunetra Gupta, considered by many to be the world's preeminent infectious disease expert explained that the way COVID vaccines are being promoted and the idea that everybody needs to be vaccinated is unscientific and suspicious.
The general scientific consensus is that more than a billion people have been infected, which is why, for most people, the survival rate of COVID is extremely high, nearly 100 percent for healthy people under the age of 60.
If this is true, there are a number of people in the population who are already immune and do not require a vaccine.
Furthermore,
I don't know but these are all very important questions.
Furthermore, questions of vaccine efficacy must be taken into consideration. You can read more about that here and here.
With all of this information and the sources available, does the idea of vaccine passports, or mandating vaccines to attend sporting events actually make sense at all?
If it doesn't, and if it's not black and white, then why is there such a strong push for these measures? Has science become politicized?
Lasting Antibody Protection May 24, 2021 from TheSource Website
are left with long-term antibody protection against future disease, according to a study from researchers at Washington University School of Medicine.
(Photo: Getty Images)
People who have had mild illness develop antibody-producing cells
that can
last lifetime...
Such cells could
persist for a lifetime, churning out antibodies all the while.
During a viral infection, antibody-producing immune cells rapidly multiply and circulate in the blood, driving antibody levels sky-high. Once the infection is resolved, most such cells die off, and blood antibody levels drop.
A small population of antibody-producing cells, called long-lived plasma cells, migrate to the bone marrow and settle in, where they continually secrete low levels of antibodies into the bloodstream to help guard against another encounter with the virus.
The key to figuring out whether COVID-19 leads to long-lasting antibody protection, Ellebedy realized, lies in the bone marrow.
To find out whether those who have recovered from mild cases of COVID-19 harbor long-lived plasma cells that produce antibodies specifically targeted to SARS-CoV-2, the virus that causes COVID-19, Ellebedy teamed up with co-author Iskra Pusic, MD, associate professor of medicine.
Ellebedy already was working with co-authors Rachel Presti, MD, PhD associate professor of medicine, and Jane O'Halloran, MD, PhD assistant professor of medicine, on a project to track antibody levels in blood samples from COVID-19 survivors.
The team already had enrolled 77 participants who were giving blood samples at three-month intervals starting about a month after initial infection. Most participants had had mild cases of COVID-19; only six had been hospitalized.
With Pusic's help, Ellebedy and colleagues obtained bone marrow from 18 of the participants seven or eight months after their initial infections. Five of them came back four months later and provided a second bone marrow sample.
For comparison, the scientists also obtained bone marrow from 11 people who had never had COVID-19.
As expected, antibody levels in the blood of the COVID-19 participants dropped quickly in the first few months after infection and then mostly leveled off, with some antibodies detectable even 11 months after infection.
Further, 15 of the 19 bone marrow samples from people who had had COVID-19 contained antibody-producing cells specifically targeting the virus that causes COVID-19. Such cells could still be found four months later in the five people who came back to provide a second bone-marrow sample.
None of the 11 people who had never had COVID-19 had such antibody-producing cells in their bone marrow.
People who were infected and never had symptoms also may be left with long-lasting immunity, the researchers speculated.
But it's yet to be investigated whether those who endured more severe infection would be protected against a future bout of disease, they said.
Ellebedy and colleagues now are studying whether vaccination also induces long-lived antibody-producing cells.
Notes
|
